15 citations
,
January 2002 in “Gynecological endocrinology”
This review discusses the extragenital effects of ovarian steroids, particularly focusing on aesthetic endocrinology, which suggests estrogens may slow skin aging post-menopause, though hair loss treatment efficacy is mainly confirmed for minoxidil.
4 citations
,
December 2002 in “Gynecological Endocrinology”
This review discusses the role of ovarian steroids in skin and hair metabolism, and suggests estrogens could slow skin aging post-menopause, while minoxidil is effective for women's hair loss.
1 citations
,
June 2001 in “Annals of Internal Medicine”
This letter to the editor discusses data from a study on troglitazone for lipodystrophy, noting significant increases in subcutaneousfat without dietary changes.
270 citations
,
April 2007 in “The Journal of Clinical Endocrinology and Metabolism”
This study found that PCOS patients had higher amounts of central abdominal fat compared to weight-matched controls, which was associated with increased insulin resistance.
Subcutaneous scalp fat may be linked to hair loss, with theories suggesting that fat loss can lead to reduced blood flow and increased DHT activity, contributing to hair loss. Treatments discussed include PRP/PRF injections and fat transfer to improve scalp thickness and blood flow.
Hair loss is linked to excess epicardial fat, which may affect blood flow to hair follicles. Treatments mentioned include minoxidil, finasteride, and dutasteride.
Finasteride has no effect on the user's estradiol levels, and body fat may influence aromatization. The user is on testosterone replacement therapy and uses everyday injections to manage high RBC count, with plans to measure DHT, DHEA-S, and pregnenolone levels.
Chime Biologics and Hope Medicine are speeding up the launch of a first-in-class antibody drug, HMI-115, for endometriosis and androgenic alopecia. The treatment involves a series of subcutaneous injections, has shown promising results in phase 1, and continues to promote hair regrowth even after the treatment is stopped.